India Court Nixes Roche Patent-Infringement Suits Against Matrix, Intas
This article was originally published in PharmAsia News
Executive Summary
An India court ruled in favor of local drug makers Matrix Pharmaceuticals and Intas Pharma in patent-infringement suits against Roche and its cancer drug Tarceva (erlotinib).